GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $16.60 $19.00 Friday, 19th Apr 2024 ACAD stock ended at $16.82. This is 1.46% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.06% from a day low at $16.62 to a day high of $17.30.
90 days $16.60 $29.29
52 weeks $16.60 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2021-06-02 $22.50 $22.98 $22.32 $22.62 1 333 440
2021-06-01 $22.51 $22.69 $21.77 $22.35 1 051 031
2021-05-28 $22.08 $22.73 $22.08 $22.34 1 013 262
2021-05-27 $21.85 $22.31 $21.60 $22.04 1 124 832
2021-05-26 $21.26 $21.76 $21.16 $21.71 1 171 415
2021-05-25 $21.34 $21.73 $21.24 $21.28 1 373 213
2021-05-24 $22.00 $22.09 $21.22 $21.32 1 269 693
2021-05-21 $21.59 $22.15 $21.41 $21.94 1 172 503
2021-05-20 $20.76 $21.67 $20.65 $21.58 1 261 537
2021-05-19 $21.24 $21.30 $20.62 $20.72 1 428 430
2021-05-18 $21.26 $21.97 $21.20 $21.39 2 187 815
2021-05-17 $21.51 $22.28 $21.02 $21.23 1 660 067
2021-05-14 $21.27 $21.94 $20.87 $21.77 1 364 927
2021-05-13 $21.85 $21.99 $20.93 $21.22 1 985 573
2021-05-12 $20.77 $22.33 $20.74 $21.83 2 298 760
2021-05-11 $20.65 $21.60 $20.36 $20.84 2 038 338
2021-05-10 $20.90 $21.27 $20.62 $21.02 1 317 313
2021-05-07 $20.89 $21.59 $20.65 $21.07 1 535 926
2021-05-06 $19.55 $20.99 $19.53 $20.95 2 696 803
2021-05-05 $19.42 $19.75 $19.20 $19.40 1 769 091
2021-05-04 $20.13 $20.23 $19.34 $19.52 2 501 953
2021-05-03 $20.54 $20.70 $20.21 $20.25 1 528 469
2021-04-30 $20.33 $20.79 $20.30 $20.56 1 264 892
2021-04-29 $20.94 $21.22 $20.43 $20.59 1 024 173
2021-04-28 $21.16 $21.18 $20.70 $20.77 1 395 126
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT